Pnina Fishman was appointed Chief Scientific Officer of Can-Fite BioPharma.
2 reports, 2 independent
Updated Jul 14
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pnina Fishman was appointed Chief Scientific Officer of Can-Fite BioPharma.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Pnina Fishman
researcher
Nothing else this week.
-
Vascular
Hungarian company
Nothing else this week.
Coverage
Newest first; wire copies grouped- manilatimes.net
- GlobeNewswireBreakthrough Study from UCLA Demonstrate Can-Fite’s Piclidenoson as a Treatment for Vascular Dementia Ramat Gan, Israel, July 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF